摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2‑hydroxy-N'-(naphthalen-2-ylmethylene)benzohydrazide | 303058-95-9

中文名称
——
中文别名
——
英文名称
2‑hydroxy-N'-(naphthalen-2-ylmethylene)benzohydrazide
英文别名
2-hydroxy-N'-(naphthalen-2-ylmethylene)benzohydrazide;MDG487;2-hydroxy-benzoic acid [1-naphthalen-2-yl-meth-(E)-ylidene]-hydrazide;2-hydroxy-N-(naphthalen-2-ylmethylideneamino)benzamide
2‑hydroxy-N'-(naphthalen-2-ylmethylene)benzohydrazide化学式
CAS
303058-95-9
化学式
C18H14N2O2
mdl
——
分子量
290.321
InChiKey
JSZPKHUEXGMRFH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.20±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    61.7
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2‑hydroxy-N'-(naphthalen-2-ylmethylene)benzohydrazide巯基乙酸溶剂黄146 作用下, 以63%的产率得到2-hydroxy-N-(2-(naphthalen-2-yl)-4-oxothiazolidin-3-yl)benzamide
    参考文献:
    名称:
    In vitro α-glucosidase and α-amylase inhibitory potential and molecular docking studies of benzohydrazide based imines and thiazolidine-4-one derivatives
    摘要:
    DOI:
    10.1016/j.molstruc.2021.132058
  • 作为产物:
    描述:
    水杨酸乙酯 在 hydrazine hydrate 作用下, 以 乙醇 为溶剂, 生成 2‑hydroxy-N'-(naphthalen-2-ylmethylene)benzohydrazide
    参考文献:
    名称:
    In vitro α-glucosidase and α-amylase inhibitory potential and molecular docking studies of benzohydrazide based imines and thiazolidine-4-one derivatives
    摘要:
    DOI:
    10.1016/j.molstruc.2021.132058
点击查看最新优质反应信息

文献信息

  • Design, synthesis, and evaluation of novel small molecule inhibitors of the influenza virus protein NS1
    作者:Joseph J. Jablonski、Dipwanita Basu、Daniel A. Engel、H. Mario Geysen
    DOI:10.1016/j.bmc.2011.10.026
    日期:2012.1
    Influenza is a continuing world-wide public health problem that causes significant morbidity and mortality during seasonal epidemics and sporadic pandemics. The existing vaccination program is variably effective from year to year, and drug resistance to available antivirals is a growing problem, making the development of additional antivirals an important challenge. Influenza virus non-structural protein 1 (NS1) is the centerpiece of the viral response to the host interferon (IFN) system. NS1 was demonstrated previously to be a potential therapeutic target for antiviral therapy by the identification of specific small-molecule inhibitors. One inhibitory compound, NSC125044, was subjected to chemical evaluation. Initial synthetic work comprised simplifying the core structure by removing unwanted functionality and determination of key features important for activity. Several subclasses of molecules were designed and synthesized to further probe activity and develop the basis for a structure-activity relationship. Apparent potency, as judged by activity in virus replication assays, increased dramatically for some analogs, without cytotoxicity. Results suggest that the target binding site tolerates hydrophobic bulk as well as having a preference for weakly basic substituents. (C) 2011 Elsevier Ltd. All rights reserved.
  • In vitro α-glucosidase and α-amylase inhibitory potential and molecular docking studies of benzohydrazide based imines and thiazolidine-4-one derivatives
    作者:Hayat Ullah、Imad Uddin、Fazal Rahim、Fahad Khan、Sobia、Muhammad Taha、Misbah Ullah Khan、Shawkat Hayat、Munzer Ullah、Zarif Gul、Shaheed Ullah、Hussan Zada、Javid Hussain
    DOI:10.1016/j.molstruc.2021.132058
    日期:2022.3
查看更多